Medical Technology Company Atlantic Therapeutics Raises €28 Million in Series B

The Ireland-based medical technology company Atlantic Therapeutics raises an investment of €28 million in Series B. The round was led by LSP, investing from its LSP Health Economics Fund 2, joined by Andera Partners, investing from its BioDiscovery 5 fund, and Atlantic Bridge Ventures, investing from the China-Ireland Growth Technology Fund. In addition, the company’s existing investors, Seroba Life Sciences and Earlybird Venture Capital, followed their investment.

The company intends to use the funds to continue the company’s growth and to enter the US market, as well as to further develop its product portfolio.

The company gained the FDA approval for their therapy device called INNOVO® – a non-invasive pelvic floor exerciser that treats the root cause of bladder weakness. The device uses electrical muscle stimulation (EMS) to optimally strengthen the pelvic floor and re-educate the muscles that play an important role in bladder control.

Home Money Talks Medical Technology Company Atlantic Therapeutics Raises €28 Million in Series B

Follow Us


Latest Videos

60seconds Live Show #14

This week we invited 4 startup representatives to pitch on our show: Michael Mörs, the founder of Epicinsights, Christian Vetter, the Co-founder and MD of HRForecast, Timur Kharrasov the CEO of Smart Wins Technologies, and Astrid Schrader, the founder of The Arc all told us about their products and the problems that they are solving.

Civey Enables Everyone to Know the World’s Intentions

Civey is a German polling institute using an automated statistical algorithm that turns public opinions into actionable insights.

How MYFLYRIGHT Helps Passengers Enforce Customer Claims

MYFLYRIGHT helps passengers acknowledge their rights when dealing with poor customer service. Tools are provided, so that passengers can claim their compensation they deserved.